본문 바로가기
KERD
논문KCI 등재

Acute-on-chronic liver failure: Terminology, mechanisms and management

Shiv Kumar Sarin|Vinay Kumar BR
대한간학회 (The korean Association for the Study of the Liver)|2023.07|Clinical and Molecular Hepatology|제29권 제3호|pp. 670-689

2

조회

0

다운로드

2

인용

0

참고문헌

키워드

Acute-on-chronic liver failureOrgan failureBile acid and saltsPlasma exchange and support system

초록

Acute-on-chronic liver failure is an acute deterioration of liver function manifesting as jaundice and coagulopathy with the development of ascites, with a high probability of extrahepatic organ involvement and high 28-day mortality. The pathogenesis involves extensive hepatic necrosis, which is associated with severe systemic inflammation and subsequently causes the cytokine storm, leading to portal hypertension, organ dysfunction, and organ failure. These patients have increased gut permeability, releasing lipopolysaccharide (LPS) and damage-associated molecular patterns (DAMPS) in the blood, leading to hyper-immune activation and the secretion of cytokines, followed by immune paralysis, causing the development of infections and organ failure in a proportion of patients. Early detection and the institution of treatment, especially in the "Golden Window" period of 7 days, gives an opportunity for reversal of the syndrome. Scores like the Asian Pacific Association for the Study of the Liver (APASL) ACLF research consortium (AARC) score, a model for end stage liver disease (MELD), and the CLIF Consortium acute-on-chronic liver failure (CLIF-C ACLF) score can help in the prediction of mortality. Treatment strategy includes treatment of acute insult. Patients should be considered for early transplant with MELD score >28, AARC score >10, high-grade hepatic encephalopathy, and in the absence of >2 organ failure or overt sepsis to improve survival of up to 80% at five years. Patients, with no option of transplant, can be treated with emerging therapies like faecal microbial transplant, plasma exchange, etc., which need further evaluation.

Abstract

Acute-on-chronic liver failure is an acute deterioration of liver function manifesting as jaundice and coagulopathy with the development of ascites, with a high probability of extrahepatic organ involvement and high 28-day mortality. The pathogenesis involves extensive hepatic necrosis, which is associated with severe systemic inflammation and subsequently causes the cytokine storm, leading to portal hypertension, organ dysfunction, and organ failure. These patients have increased gut permeability, releasing lipopolysaccharide (LPS) and damage-associated molecular patterns (DAMPS) in the blood, leading to hyper-immune activation and the secretion of cytokines, followed by immune paralysis, causing the development of infections and organ failure in a proportion of patients. Early detection and the institution of treatment, especially in the "Golden Window" period of 7 days, gives an opportunity for reversal of the syndrome. Scores like the Asian Pacific Association for the Study of the Liver (APASL) ACLF research consortium (AARC) score, a model for end stage liver disease (MELD), and the CLIF Consortium acute-on-chronic liver failure (CLIF-C ACLF) score can help in the prediction of mortality. Treatment strategy includes treatment of acute insult. Patients should be considered for early transplant with MELD score >28, AARC score >10, high-grade hepatic encephalopathy, and in the absence of >2 organ failure or overt sepsis to improve survival of up to 80% at five years. Patients, with no option of transplant, can be treated with emerging therapies like faecal microbial transplant, plasma exchange, etc., which need further evaluation.

참고문헌 (98)

  1. Sarin SK, "Acute-on-chronic liver failure : consensus recommendations of the Asian Pacific association for the study of the liver(APASL) : an update", Hepatol Int, 13, pp.353~390 (2019)
  2. Moreau R, "Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis", Gastroenterology, 144, pp.1426~1437 (2013)
  3. de Franchis R, "Baveno VII-Renewing consensus in portal hypertension", J Hepatol, 76, pp.959~974 (2022)
  4. Jalan R, "The CLIF Consortium Acute Decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure", J Hepatol, 62, pp.831~840 (2015)
  5. Arroyo V, "Acute-on-chronic liver failure : A new syndrome that will re-classify cirrhosis", J Hepatol, 62(1Suppl), pp.S131~S143 (2015)
  6. Thuluvath PJ, "Liver transplantation in patients with multiple organ failures : Feasibility and outcomes", J Hepatol, 69, pp.1047~1056 (2018)
  7. Vincent JL, "The SOFA(Sepsis-related Organ Failure Assessment)score to describe organ dysfunction", failure, 1996, pp.22, 707~710
  8. Wehler M, "Shortterm prognosis in critically ill patients with cirrhosis assessed by prognostic scoring systems", Hepatology, 34, pp.255~261 (2001)
  9. Das V, "Cirrhotic patients in the medical intensive care unit : early prognosis and long-term survival", Crit Care Med, 38, pp.2108~2116 (2010)
  10. Levesque E, "Prospective evaluation of the prognostic scores for cirrhotic patients admitted to an intensive care unit", J Hepatol, 56, pp.95~102 (2012)
  11. Singh KK, "Patients with diabetes mellitus are prone to develop severe hepatitis and liver failure due to hepatitis virus infection", J Clin Exp Hepatol, 3, pp.275~280 (2013)
  12. Sarin SK, "Acute-on-chronic liver failure : terminology, mechanisms and management", Nat Rev Gastroenterol Hepatol, 13, pp.131~149 (2016)
  13. Yu S, "The efficacy and safety of nucleos(t)ide analogues in the treatment of HBV-related acute-on-chronic liver failure : a meta-analysis", Ann Hepatol, 12, pp.364~372 (2013)
  14. Aoki J, "Kinetics of peripheral hepatitis B virus-specific CD8+ T cells in patients with onset of viral reactivation", J Gastroenterol, 48, pp.728~737 (2013)
  15. Kumar Acharya S, "Hepatitis E virus(HEV)infection in patients with cirrhosis is associated with rapid decompensation and death", J Hepatol, 46, pp.387~394 (2007)
  16. Blasco-Perrin H, "Hepatitis E virus in patients with decompensated chronic liver disease : a prospective UK", French study, 2015, pp.42, 574~581
  17. Sehgal R, "Impaired monocyte-macrophage functions and defective Tolllike receptor signaling in hepatitis E virus-infected pregnant women with acute liver failure", Hepatology, 62, pp.1683~1696 (2015)
  18. Saravanabalaji S, "Viral load, antibody titers and recombinant open reading frame 2 protein-induced TH1", TH2 cytokines and cellular immune responses in self-limiting and fulminant hepatitis E, 2009, pp.52, 78~85
  19. Devarbhavi H, "Single-center experience with drug-induced liver injury from India : causes, outcome, prognosis, and predictors of mortality", Am J Gastroenterol, 105, pp.2396~2404 (2010)
  20. "Hepatology", 2014, 553A~
  21. Gabrielli M, "Steatotic livers. Can we use them in OLTX? Outcome data from a prospective baseline liver biopsy study", Ann Hepatol, 11, pp.891~898 (2012)
  22. Angulo P, "Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis", Hepatology, 30, pp.1356~1362 (1999)
  23. Loomba R, "The global NAFLD epidemic", Nat Rev Gastroenterol Hepatol, 10, pp.686~690 (2013)
  24. Third GoI-WHO-ILBS National Technical Consultation on Viral Hepatitis Towards a National Action Plan for Viral Hepatitis (NAP-VH), "MoHFW", ~ (2016)
  25. Kulkarni AV, "Primary norfloxacin prophylaxis for APASL-defined acute-on-chronic liver failure : A placebo-controlled doubleblind randomized trial", Am J Gastroenterol, 117, pp.607~616 (2022)
  26. Mathurin P, "Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis : meta-analysis of individual patient data", Gut, 60, pp.255~260 (2011)
  27. Gao B, "Alcoholic liver disease : pathogenesis and new therapeutic targets", Gastroenterology, 141, pp.1572~1585 (2011)
  28. Sundaram V, "Class III obesity is a risk factor for the development of acute-on-chronic liver failure in patients with decompensated cirrhosis", J Hepatol, 69, pp.617~625 (2018)
  29. Fernández J, "Bacterial and fungal infections in acute-on-chronic liver failure: prevalence, characteristics and impact on prognosis", Gut, 67, pp.1870~1880 (2018)
  30. Li H, "Characteristics, diagnosis and prognosis of acute-on-chronic liver failure in cirrhosis associated to hepatitis B", Sci Rep, 6, pp.25487~ (2016)
  31. Choudhury A, "Systemic inflammatory response syndrome in acute-on-chronic liver failure:Relevance of ‘golden window’: A prospective study", J Gastroenterol Hepatol, 32, pp.1989~1997 (2017)
  32. Wu T, "Development of diagnostic criteria and a prognostic score for hepatitis B virusrelated acute-on-chronic liver failure", Gut, 67, pp.2181~2191 (2018)
  33. Choudhury A, "Liver failure determines the outcome in patients of acute-on-chronic liver failure (ACLF): comparison of APASL ACLF research consortium (AARC)and CLIF-SOFA models", Hepatol Int, 11, pp.461~471 (2017)
  34. Rastogi A, "Liver histology as predictor of outcome in patients with acuteon-chronic liver failure(ACLF)", Virchows Arch, 459, pp.121~127 (2011)
  35. Myers RP, "Transient elastography for the noninvasive assessment of liver fibrosis : a multicentre Canadian study", Can J Gastroenterol, 24, pp.661~670 (2010)
  36. Ginès P, "Renal failure in cirrhosis", N Engl J Med, 361, pp.1279~1290 (2009)
  37. Maiwall R, "AKI in patients with acute on chronic liver failure is different from acute decompensation of cirrhosis", Hepatol Int, 9, pp.627~639 (2015)
  38. Arora V, "Terlipressin is superior to noradrenaline in the management of acute kidney injury in acute on chronic liver failure", Hepatology, 71, pp.600~610 (2020)
  39. Kulkarni AV, "Prophylactic perioperative terlipressin therapy for preventing acute kidney injury in living donor liver transplant recipients : A systematic review and meta-analysis", J Clin Exp Hepatol, 12, pp.417~427 (2022)
  40. Jha AK, "Etiology, clinical profile, and inhospital mortality of acute-onchronic liver failure : a prospective study", Indian J Gastroenterol, 32, pp.108~114 (2013)
  41. Wan YM, "Therapeutic plasma exchange versus double plasma molecular absorption system in hepatitis B virus-infected acute-on-chronic liver failure treated by entercavir : A prospective study", J Clin Apher, 32, pp.453~461 (2017)
  42. Gupta T, "Characterization of cerebral edema in acute-on-chronic liver failure", J Clin Exp Hepatol, 7, pp.190~197 (2017)
  43. Blasi A, "Coagulation failure in patients with acute-onchronic liver failure and decompensated cirrhosis : Beyond the international normalized ratio", Hepatology, 68, pp.2325~2337 (2018)
  44. Premkumar M, "Coagulation failure is associated with bleeding events and clinical outcome during systemic inflammatory response and sepsis in acute-on-chronic liver failure : An observational cohort study", Liver Int, 39, pp.694~704 (2019)
  45. Premkumar M, "Heparin-like effect associated with risk of bleeding, sepsis, and death in patients with severe alcohol-associated hepatitis", Clin Gastroenterol Hepatol, 18, pp.486~495 (2020)
  46. Shasthry SM, "Efficacy of granulocyte colony-stimulating factor in the management of steroid-nonresponsive severe alcoholic hepatitis : A doubleblind randomized controlled trial", Hepatology, 70, pp.802~811 (2019)
  47. Garg V, "Granulocyte colony-stimulating factor mobilizes CD34(+)cells and improves survival of patients with acute-on-chronic liver failure", Gastroenterology, 142, pp.505~512 (2012)
  48. Hou W, "Effect of a carbohydrate-containing late-evening snack on energy metabolism and fasting substrate utilization in adults with acute-on-chronic liver failure due to Hepatitis B", Eur J Clin Nutr, 67, pp.1251~1256 (2013)
  49. Zaccherini G, "Acute-on-chronic liver failure : Definitions, pathophysiology and principles of treatment", JHEP Rep, 3, pp.100176~ (2020)
  50. Chan AC, "Liver transplantation for acute-on-chronic liver failure", Hepatol Int, 3, pp.571~581 (2009)
  51. Kumar V, "Degree of hemodynamic derangements correlate with poor outcomes in acute on chronic liver failure(ACLF)patients", Hepatology, 68(1 Suppl) (2018)
  52. Laleman W, "Acute-on-chronic liver failure : current concepts on definition, pathogenesis, clinical manifestations and potential therapeutic interventions", Expert Rev Gastroenterol Hepatol, 5, pp.523~537 (2011)
  53. Clària J, "Systemic inflammation in decompensated cirrhosis: Characterization and role in acute-on-chronic liver failure", Hepatology, 64, pp.1249~1264 (2016)
  54. Maiwall R, "Dynamic AARC-AKI score determines Extrarenal Organ Failures and Bacterial Infection in patients with Acute on Chronic Liver Failure", Hepatology, 66(1 Suppl) (2017)
  55. Krenitsky J, "Nutrition for patients with hepatic failure", Pract Gastroenterol, 6, pp.23~42 (2003)
  56. Zhang B, "n-3 fatty acidbased parenteral nutrition improves postoperative recovery for cirrhotic patients with liver cancer : A randomized controlled clinical trial", Clin Nutr, 36, pp.1239~1244 (2017)
  57. JavierF JA, "Bacterialandfungal infections in acute-onchronic liver failure : prevalence, characteristicsandimpactonprognosis", Gut, 67, pp.1870~1880 (1880)
  58. Sargenti K, "Predictors of mortality among patients with compensated and decompensated liver cirrhosis : the role of bacterial infections and infectionrelated acute-on-chronic liver failure", Scand J Gastroenterol, 50, pp.875~883 (2015)
  59. Bajaj JS, "Survival in infection-related acute-onchronic liver failure is defined by extrahepatic organ failures", Hepatology, 60, pp.250~256 (2014)
  60. Jalan R, "Role of predisposition, injury, response and organ failure in the prognosis of patients with acute-on-chronic liver failure : a prospective cohort study", Crit Care, 16, pp.R227~ (2012)
  61. Garg H, "Tenofovir improves the outcome in patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure", Hepatology, 53, pp.774~780 (2011)
  62. Chauhan A, "Fecal microbiota transplantation in hepatitis B e antigen-positive chronic hepatitis B patients : A pilot study", Dig Dis Sci, 66, pp.873~880 (2021)
  63. Jalan R, "Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure", J Hepatol, 61, pp.1038~1047 (2014)
  64. Louvet A, "Infection in patients with severe alcoholic hepatitis treated with steroids : early response to therapy is the key factor", Gastroenterology, 137, pp.541~548 (2009)
  65. Engelmann C, "Granulocyte-colony stimulating factor(G-CSF)to treat acute-on-chronic liver failure : A multicenter randomized trial(GRAFT study)", J Hepatol, 75, pp.1346~1354 (2021)
  66. Gustot T, "Clinical Course of acute-on-chronic liver failure syndrome and effects on prognosis", Hepatology, 62, pp.243~252 (2015)
  67. Anand L, "Flare of autoimmune hepatitis causing acute on chronic liver failure: Diagnosis and response to corticosteroid therapy", Hepatology, 70, pp.587~596 (2019)
  68. Devarbhavi H, "Acute on chronic liver failure secondary to drugs : causes, outcome and predictors of mortality", J Hepatol, 64(2 Suppl), pp.S232~ (2016)
  69. Selva Rajoo A, "Acute-on-chronic liver failure in a multi-ethnic Asian city : A comparison of patients identified by Asia-Pacific Association for the Study of the Liver and European Association for the Study of the Liver definitions", World J Hepatol, 9, pp.1133~1140 (2017)
  70. Vyas TS, "Goal directed ammonia lowering therapy in acute on chronic liver failure(ACLF)with hepatic encephalopathy(HE) : a randomized trial(clinicaltrials. gov identifier : NCT02321371)", J Clin Exp Hepatol, 7(Suppl 1), pp.S19~S20 (2017)
  71. Jindal A, "Evaluation of acute kidney injury and its response to terlipressin in patients with acute-on-chronic liver failure", Liver Int, 36, pp.59~67 (2016)
  72. Maiwall R, "SIRS at admission is a predictor of AKI development and mortality in hospitalized patients with severe alcoholic hepatitis", Dig Dis Sci, 61, pp.920~929 (2016)
  73. Bernardi M, "Albumin in decompensated cirrhosis : new concepts and perspectives", Gut, 69, pp.1127~1138 (2020)
  74. Fernández J, "Effects of albumin treatment on systemic and portal hemodynamics and systemic inflammation in patients with decompensated cirrhosis", Gastroenterology, 157, pp.149~162 (2019)
  75. O’Brien AJ, "Immunosuppression in acutely decompensated cirrhosis is mediated by prostaglandin E2", Nat Med, 20, pp.518~523 (2014)
  76. Piano S, "Response to terlipressin and albumin is associated with improved liver transplant outcomes in patients with hepatorenal syndrome", Hepatology, 73, pp.1909~1919 (2021)
  77. Staufer K, "Renal replacement therapy in critically ill liver cirrhotic patients-outcome and clinical implications", Liver Int, 37, pp.843~850 (2017)
  78. Gonwa TA, "The challenges of providing renal replacement therapy in decompensated liver cirrhosis", Blood Purif, 33, pp.144~148 (2012)
  79. Cardoso FS, "Continuous renal replacement therapy is associated with reduced serum ammonia levels and mortality in acute liver failure", Hepatology, 67, pp.711~720 (2018)
  80. Wan ZH, "Cystatin C is a biomarker for predicting acute kidney injury in patients with acute-on-chronic liver failure", World J Gastroenterol, 19, pp.9432~9438 (2013)
  81. Wong LP, "Survival of liver transplant candidates with acute renal failure receiving renal replacement therapy", Kidney Int, 68, pp.362~370 (2005)
  82. Chen J, "Early diagnostic biomarkers of sepsis for patients with acuteon-chronic liver failure : A multicenter study", Infect Dis Ther, 10, pp.281~290 (2021)
  83. Singh V, "Midodrine and clonidine in patients with cirrhosis and refractory or recurrent ascites : a randomized pilot study", Am J Gastroenterol, 108, pp.560~567 (2013)
  84. Bajaj JS, "Linkage of gut microbiome with cognition in hepatic encephalopathy", Am J Physiol Gastrointest Liver Physiol, 302, pp.G168~G175 (2012)
  85. Im GY, "Liver transplantation for alcoholic hepatitis", J Hepatol, 70, pp.328~334 (2019)
  86. Putignano A, "New concepts in acute-on-chronic liver failure : Implications for liver transplantation", Liver Transpl, 23, pp.234~243 (2017)
  87. Sundaram V, "Factors associated with survival of patients with severe acuteon-chronic liver failure before and after liver transplantation", Gastroenterology, 156, pp.1381~1391 (2019)
  88. Asrani SK, "Recipient characteristics and morbidity and mortality after liver transplantation", J Hepatol, 69, pp.43~50 (2018)
  89. Mahmud N, "Grade 1 acute on chronic liver failure is a predictor for subsequent grade 3 failure", Hepatology, 72, pp.230~239 (2020)
  90. Mathurin P, "Early liver transplantation for severe alcoholic hepatitis", N Engl J Med, 365, pp.1790~1800 (2011)
  91. Pamecha V, "Liver transplantation in acute on chronic liver failure : challenges and an algorithm for patient selection and management", Hepatol Int, 9, pp.534~542 (2015)
  92. Martin P, "Evaluation for liver transplantation in adults : 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation", Hepatology, 59, pp.1144~1165 (2014)
  93. Bertuzzo VR, "Impact of preoperative infection on outcome after liver transplantation", Br J Surg, 104, pp.e172~e181 (2017)
  94. Singal AK, "ACG clinical guideline : alcoholic liver disease", Am J Gastroenterol, 113, pp.175~194 (2018)
  95. Thursz M, "Alcoholrelated liver disease : Areas of consensus, unmet needs and opportunities for further study", J Hepatol, 70, pp.521~530 (2019)
  96. Singal AK, "Outcomes after liver transplantation for alcoholic hepatitis are similar to alcoholic cirrhosis : exploratory analysis from the UNOS database", Hepatology, 55, pp.1398~1405 (2012)
  97. Dom G, "Addiction specialist’s role in liver transplantation procedures for alcoholic liver disease", World J Hepatol, 7, pp.2091~2099 (2015)
  98. Lee BP, "Predicting low risk for sustained alcohol use after early liver transplant for acute alcoholic hepatitis : The sustained alcohol use post-liver transplant score", Hepatology, 69, pp.1477~1487 (2019)

관련 논문AI추천

Acute-on-chronic liver failure as a major predictive factor for mortality in patients with variceal bleeding김동준, 석기태, 신종범, Chang-Wook Kim, Do Seon Song, Eileen L. Yoon, Hee Yeon Kim, Hyung Joon Yim, Jae Young Jang, Jin Mo Yang, Jung Hwan Yu, Korean Acute-on-Chronic Liver Failure (KACLiF) Study Group, Sang Gyune Kim, Sang Soo Lee, Soung Won Jeong, Young-Joo Jin, Young Kul Jung, Young Seok Kim대한간학회 · Clinical and Molecular Hepatology2020 · 제26권 제4호Static and dynamic prognostic factors for hepatitis-B-related acute-on-chronic liver failure손원, 고광철, 곽금연, 백승운, 백용한, 신동현, 이준혁, 조주연, 최문석, Byung Chul Yoo, Jeung Hui Pyo, Jung Min Ha, Kyu Choi대한간학회 · Clinical and Molecular Hepatology2015 · 제21권 제3호Acute-on-chronic liver failure: A predictor of poor prognosis in patients with variceal bleeding or a risk factor for variceal bleeding?Nae Yun Heo대한간학회 · Clinical and Molecular Hepatology2020 · 제26권 제4호The fibrogenic process and the unleashing of acute-on-chronic liver failureGuillermo Nahúm López-Sánchez, Mayra Dóminguez-Pérez, Misael Uribe, Natalia Nuño-Lámbarri대한간학회 · Clinical and Molecular Hepatology2020 · 제26권 제1호Emerging medical therapies for severe alcoholic hepatitisDavid Tornai, Gyongyi Szabo대한간학회 · Clinical and Molecular Hepatology2020 · 제26권 제4호Hepatitis E as a trigger for acute-on-chronic liver failureJuan Carlos Ruiz-Cobo, Maria Buti, Mar Riveiro-Barciela, Rafael Esteban대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제1호

이 간행물의 다른 논문 (26건)

Transarterial chemoembolization for hepatocellular carcinoma: 2023 Expert consensus-based practical recommendations of the Korean Liver Cancer AssociationHyunchul Rhim, 김경민, Jin Woo Choi, Hee Ho Chu, Jung Suk Oh, In Joon Lee, Dong Hyeon Lee, Byung Chan Lee, Yuri Cho, Han Ah Lee, Dongho Hyun, Hoon Kwon, Kun Yung Kimpp. 521-541KASL clinical practice guidelines for management of autoimmune hepatitis 2022The Korean Association for the Study of the Liver (KASL)pp. 542-592Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma in the era of chemo-diversityTakumi Kawaguchi, Tomotake Shirono, Hideki Iwamoto, Takashi Niizeki, Shigeo Shimosepp. 593-604Development of hepatocellular carcinoma in treated and untreated patients with chronic hepatitis B virus infectionChih-Lin Lin, Jia-Horng Kaopp. 605-622Acute hepatitis C virus infection: clinical update and remaining challengesJia-Horng Kao, Chen-Hua Liupp. 623-642
원문 보기